ITRM vs TMO · rev $390.0K vs P/E 24, rev $44.56B
Iterum Therapeutics PLC (ITRM) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
Iterum Therapeutics PLC (ITRM) is a biotechnology company listed on US.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Latest reported ITRM revenue for 2025-09-30 was $390.0K. Net income was -$20.4M. ITRM currently screens at market cap $38.6M.
Latest reported TMO revenue for 2025-12-31 was $44.56B. Net income was $6.70B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
ITRM currently screens at market cap $38.6M. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the ITRM and TMO stock pages for the full models.
Not investment advice.